We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal enzyme activities from Dried Blood Spots using Clinical Mass Spectrometry. This new assay will enable us faster turn-around times.
The assay was fully validated, and approved and accredited according to ISO 15189.
Please note that the cut-offs will change as follows:
a-Galactosidase A for Fabry disease
acid a-1,4-Glucosidase for Pompe disease
acid Sphingomyelinase for Niemann-Pick A/B disease (ASMD)
ß-Glucocerebrosidase for Gaucher disease
General information for you: The measurement of an enzyme activity and its cut-off is depending on substrates used, incubation temperature and time, and may differ from assay to assay, and lab to lab.
Please do not hesitate to contact us: info(at)archimedlife.com
Your ARCHIMED Life Science Team.